TELETRADER News
12/12/2022, 1:10 PM
(Source: TeleTrader)
Merck+0.34%
Merck starts tender offer for Imago BioSciences at $36 per share
Merck & Co. Inc., also known as MSD outside of the United States and Canada, announced Monday that it had offered to buy all outstanding shares of Imago BioSciences Inc.
"Upon the successful closing of the tender offer, stockholders of Imago will receive $36 in cash for each share of Imago common stock validly tendered and not validly withdrawn in the offer," the company stated while adding that following the acquisition, Imago will merge with a subsidiary of Merck.
The tender offer is scheduled to mature one minute after 11:59 pm ET on January 10, 2023, and the deal is expected to close in the first quarter of 2023.